ࡱ> PSO bjbjWW 55 #DDDDD$hhhPho%$$$$$$$$$$$'5*%D$$$$$%DD4)%$FDD$$$rj#TF$)2j^#$?%0o%#z**F$*DF$$$$$$$$%%$$$o%$$$$*$$$$$$$$$ :  Physician to Physician Letter Template Guidance while using this template: The purpose of this letter is to recruit potential subject referrals from other clinicians (such as a primary care physician or specialists that is already known to the subject).In order to provide the outside physician additional information regarding the trial it may be useful to provide them with a protocol summary, copy of the consent form or additional recruitment materials. Please remember that beyond telling their patients about the study or distributing information, the recruiting physician is not permitted to perform any study related activities (such as, answer questions about the research, consent subjects, conduct study screening, etc.) unless they are an approved co-investigator on the protocol. Directions for use: Anything in blue/in brackets should be filled in with information that is specific to your study. Additional study specific information may be entered as needed. [Date] [Physician Name] [Physician Address] Re: Collaboration on a clinical trial [include the protocol name and/or number and clinicaltrials.gov reference if applicable] Dear [Physician Name], I would like to inform you about a research study that may be of interest to your patients and ask you to consider referring your patients to me for possible participation in the study. [Provide a brief description of the therapy under investigation/ primary objectives of the study. Include the population that has been selected and the reason why. Also include the number of subjects that need to be recruited and if or when recruitment will begin and is anticipated to conclude. It is also helpful to include details about number of visits and patient commitment expectations. Additional protocol details can be added as necessary and specific to the study.] Patients that meet the following criteria may be eligible for our study: [Include the main inclusion/exclusion criteria for the study. More detailed information could be provided in supplemental materials.] I look forward to speaking with potential subjects in your practice who may be interested in participating in this study. Please do not hesitate to contact me with any questions or concerns. You may also have your patients contact my research team directly with any potential questions or concerns. Best Regards, [PI signature Name] [List of other contacts as applicable. Consider putting the name of a research nurse, designated co-investigator or CRC.]      V1.0 2014-08  '()LM ( & D  / 0 1  + T Ȼ{lb{YPhuh#i^JhuhO=^Jh0hA6^Jh0hA6B*^Jphh0hO=6B*^JphhI,hO=CJ ^JaJ hfRCJ^JaJhth!RCJ^JaJhthfRCJ^JaJhthtCJ^JaJhthiCJ^JaJhtht5CJ^JhO=5CJ^JhthO=5CJ^Jh?95CJ^J() 0 1    Y Z 673gdO= & Fgd) $a$gdt$a$gdO=T y Z 56BJ3BCDHRXYĵęֵփtj]PhI,h#iCJ^JaJhI,h?9CJ^JaJh?9CJ^JaJh0h?96B*^Jphhuh#iB*^JphhuhI,^Jh0h!R6B*^Jphhuh#iB* ^Jphph0h#i6B*^Jphhuh#i^Jhuhl^Jh0hO=6B*^JphhuhO=^Jhuhi^Jhuh!R^J34BDXY  $(gd?90^0gd?9gd00^0gd0dgd!Rgd?9 gdI,gdO=ķ֢hI,h#iCJ^JaJh+$!j$hMh?9CJU^JaJhMh?9CJ^JaJhMh?96CJ^JaJh&h?9h0(jh'h0OJQJUmHnHuhDIjhDIUgd?9?0P1h:pI,/ =!"#$v%  Dp? 0P1h:p?9/ =!"#$v%  Dp$Dd p  s >A?Picture 1"b#U~tqx]#Dn#U~tqx]PNG  IHDRx,l!1sRGB pHYs+#fIDATx^] uf&(Rkcx1WRMMJ$b4FJm4DJvI(8ӂ Fl4v+6&rǙ3qB{Ϝ93ߜyq嗎(# 9tP|΂ٔ!%}# ZK j{>f ҟt*"?b);6eAW|G@qYKUq zoW2ćc{WA Bz{.Os(`F,:#Pmt͡7a⠕ݞ"j]1ug)pf/H'/>s]oV'")4*IU xbI 8C@R%]=?10|9%[g z8a FޕNys+ݿ// 3~?fsPc5T7ͥ?֞BbоI۫ jˎ&/`9uڊddl]m_67}'^!w[WiVe-|l\+RhfC_ UGAm&_3“f\pP8u`]oٸs~s{©gݭU#?iP_7ٙ._4(I][朢~aW&|ehIU/η_ K. M9jϘȻ`~924[ժf {xS>{s7u]@wjɽq1jW*=t_7/p#)s^;y_z%Κk1}ŠHoG?hߒ{/􃠘^yÚ\pۃދoV 1Wi.Jh{}o_;0/_桑#i#ߜ- @(us6vHm2DW@jkRQo 0NXCr+1AFyߴc=frTs) ;^9_Eh*t}.y%fw)0b2)hCYh*Z/F3s LԂMto`vܡo6VtH^4]TZs[FC=GR]WEB`uhQKujqdm8Igr#E |ͬ D`J4p[)bGl`P]律bG;msdހ6S9(@`4d(blgA)*f?̸q?{,Ɗ76=Zj~0I9;kS(U=XS!\;3> 8q&E A!x[JV`y-C7(xXT`Cl"Y:UBqh P`"P!rN*3YLlSoE";cwwΘb58LP i- _'D ";LtXA TEXN`Rr7@rWݽQld ÄWCEb( q BĤXK?/9#8=܊ŵ@A J眏9D42;qY|O`+uD/8E^),(`I~<тpԃ2&%R 0vMDp(ė8 h"Zԉ5!'cb?>Տz?+[3=)OdG`c}y{#G~@.O:(NDcW\`@2čuO~U}{N9ZT!Ѱ)qM/}-ćOu,j)!BgJ=+KdQ#G*0q{xlLUYgS_"( uJ {.!+aE&ߒa ʓq>2ޯS[>hl\r b)1waڨmJFK+@WAPg 3żp ŊcOP#VZy5.*r1Jm.Agŭ8Ѳ63Kb8ؾ_ް滂-0i0xǚUn߂wa'wnZԀ4֣i«ZST13PWCb@Kݴn [ dOi40Vtk3VS]~iDrH+ xg" 0U3%ȩ] rk"\E_߆z#HLb1%0#n9u B?2܉0瓿~ $ R>kԪzOA~EcP-TrUr Oאy!Jai=t+rvuX)c"b+q7]rŭ7.:t<恌9#f_L'{?{SDH><@Z e1f9TS'n\,,R&B?=k;,Oj. j{1Q~h^xP!SN# 6&fm/>/>mgu$Nu:<:f޿;(U%ʵ_|BW8մL1=qTrv9x)Ԃ^S;fp𝭄Dc` 'Ϸ07y jH"n!"Z PwoZHc 'nPeqke9%3"_L ]! ܑ 8&y\fp{@,Qkw"0!D6FzXj;x6TЛjoFP[[ Tg G3g5jU&wBMN>-°*t/;E!@ o(B*ʋ0hI0dǧ3̮ bc#(/6[}lX>T: tw=:B&{5% t * ,lRFҟv2#ԝ?hs'Wsn/j_4f$,,'\m;6n]MKժw-f?;V10v>qc5\MowJ%!XiE$D!'>{qL€RG@R^lvџ A\5(/{U,:ѓWj[Opz#)ƍ/n{Q=HNZK:k]gr4Wxa~anhl0Vd 7 2cc\[5ͩyr_a@NCLaƛ6L.9`Jg(JY?ag51 2/I@aAn"q'II' >͂D>a7^\ |lM#AE6@W0%R:|J)&ȝfꦿ,] X7 } 'BZUB{pj.¶V+.}xyݹwpujdt,@ˀURf p rgD Z"L;2_p&P$~{"d)^-Z)dZSRmϲ$Qit Y ,l#)ӾhєԔqfrs ~"@D+ @\7͍I$/o^$pl=|UVɪ{S 0CUi> ؝!2`P@T0kO}^%T;0pZ ŽyDޗb(~IMWW9ܪz*? 9)o"dÀv|+5d'2"R3NY-1]:BS>Z5@Y[ՔDRjM﨣dd+~jƊ 8xYX{N2AiFsr1w8.7+g@$Sj?<>x8wf?O$9 ΅M}DTjs(kqf#=H=Ym89y,vF+E>@Ԍݾs], JFNUSPiM.tKrid!/H!?Y;0ry E P%U0kr>YbY0,J zmH/qxENk7Ih{Zīʧ P1O~Mt,ky W]bk[8xZ^=fגmVG="jiI^S:~RW˾HpRx,꾭x+6])/$ EOΚ%a UnrXq:A8$_\4r%Ycq[Q)'X8VFP ǡbܳ7IcqO<B֖qm""Mf~),:, 9р~iV{qW+yEIJstu8}|*ޔܗ x("b͑OtD *5Zjpu&c-u#akmf;om,ҫVbȗlYՔd ΄>PPYrπ zs۩̅@SKc%6r G?gO2 煙!<Q@B͚,:?ٽ /dF5؇忘<ڬ r^2REW#))#OU3.:[ū6|&.EE6Yh9LryDk|Aq -|uf_Zůkn`[+dvVP?fP8Fˡv`^ 1u@b@ya:ĭ)WE;|pfN`z&q-lq6*5-OAQ{ WvhqbiE80&.1b+@w!`U1/@UQʃ xj=W#I+VLbU%~"F(~TZ֋Y).6rū< >WHT=('k7_ &/Pp%Fb޲,a3 LDg kc@Q5o3-@ kƪT)3V=h-CUD4o=>i-&9/>&^;b$@37 Dcy w)_ ^{P 631ۈmɄspZӸYhR6M <.a|x2{Cĵ3bf0o,:f`v ڸ`_:Hx8o W̼UmnSaI*G ?rVFuex51;Dk@!K_|Eӟk9M4{y BT:6AY^u2Z=136Tbq`Y@іq Hl\#'@h$b㧿W V}B^l%Ī5&+S [spĢĴ:Ȁ>E>Y;Wý^'6dN45>F" JeUx´J(䤽 5`tLz>&d]z>R3rަ7[b"pt1شYj&{[S5X(R{As `1{#[gfaecov\޶i,!> >{xӨ ́=xyOvT3qUnşoR@76sF("̘ᝏOtɤi@LV+h|^c*BOXg/9>XZo'2#Ä1 S?1#Plh-ˌ4+jUP.vV=|:Ԣ Phɯw ,I(Cc'RuAUgzWUiU+c "ʀ>)|HA Eӟƀ7׫?r!he}-z ]@ (n ["EꁽRh?28sNPc{벞^w."w~Mu^9l2.[ i=g}~"3p=Vn3N7眈Wᆵ: /$%̜{)pnu,)A 'i |Ѡ&^{$?WNGy*(L_[rBقV27ַ?0ƥaG΍pDW)+`.VF4(ӌJOM5g5 4#vd5f K_/)h q30#h@Ц'*;4x]:Hio/NQrx]Pݩ@my͵&-]i|q Mɦjf'7zi^&(vӜ ݞCE]AHv::VSo,ĕ۱p%p) e:|UA ֟8DвCjCV .#ɚkڕyg81^N7Aa^佁dMR.\fo3Uui ?]}zIsLDM |9htZ#,/Z{1YNRc(3 %;0SEW 'ԭhKM71 ěW͗ k%/o)i-290e 3xoed+.0CEk$sruYaiBXTHMalh]KC|сᚙKd.KPtrF يDŽo$&\}Ak< jrHi/M+Dp]yolkt,3q3ٟ+T82u!kBthNf]4}6V\sMFKՉlWVv6wLD੄NT [v%4/4Q$C| ]|k72zBے>3㲿Ǥ6ޞ51bfyA2)ϟg%ƳCHi#%u4M,3kr^orv ?mA'c$]'*d6BYq.j?~ZJ .Ђ rP[ c5,fџ7:.M|oǨ$O-fWFo"2tWbb k&p(KfWTϤ6S҃q"XujT/誗ۭc+"1r W@A}3!?m0U Dk';p1ax4-1Or(0VG #ПO2ޕiG.b-%O*=nͬYYCU֮1*FL^8M"ܜX')ZZy3AH#le,?7)9g3D %Թ97 JXHX GVeks%HV٫@Nߵ‘7m(.αǐ.tF[dRt!6@HC ]t7~btX2ܥ0%cɦXG\|3$*>>- @JˀL6+@I7i.cgqS nfn> =OGu=ٸ=9RifmVh$GH7ɫ`Jovq/. L>]axؐ;nbںA[#]CJWFW&\y*CP;GH@&\ tm{IҖb()@:7BrAH5e.$!Z~^ˆtz J{-.CHWObYlK(L3ho(""@ى7zXyjDy^{ ]ěhmafF '! ÈhJ\t1J54i.;Bt%_u5)7bIp8l ̂!S`:k^QlJ%\c rHin3Kʬ颱b6d : ] 2\f3֒|2>=߬ eZKռfSKq|cz4k,OvמJ*<]t9@9#MJ?ܱLu$=@ OEg7 {V ݘltEjMFf+tq+kcr?3s-{JxOezJ R:*sjl:U~:=.r.w:kM B53&7XD-I}H_\9|si7{no^2t}zS!c9/;W ?',g笕mJ} !8r|߶c"[>"VUn~zҽ]D'viv;=oRNio?FnPU4vv>ÎbYy|.p(ݨ|J']tj#}NT U}EHG~4Fq\tb+2469 _6GX˕5Z!zBH7tE:Lm=|q]mM:]S6nVe߾\IY1cDc<^H^Й}wjθUxc^M_m8{}Ďe /;מE*72[zac~74鵟ާỈKBƗ}.OӗHWO*%cIwԋ^oKOEǖmk-Pzi~+qNuDiR -pKyzIh]m-|gN2p#7gMltKq_0Gc9U_WN <!6'} KnK־b+ݐţnt_Q׷ac9U_W+alx!i$*nv+{=~mF޲N o> u&ݐ6G]c_!kY,ʭd2Seto֎u> xɾ+ҴlH~Kcqxe|L-.3E{GG\sPIENDB`j 002 0@P`p2( 0@P`p 0@P`p 0@P`p 0@P`p 0@P`p 0@P`p8XV~ OJPJQJ_HmH nH sH tH R`R KONormald$CJOJPJQJ_H aJmH sH tH DA D Default Paragraph FontRiR  Table Normal4 l4a (k (No List RoR n Paragraph CJOJQJ_H aJmH sH tH PoP n Paragraph CharCJOJQJ^JmH sH tH D@D Yy Balloon TextCJOJQJaJB'`!B fRComment ReferenceCJaJ<@2< fR Comment TextCJaJJoAJ fRComment Text CharOJPJQJ_H @j@12@ fRComment Subject5\VoaV fRComment Subject Char5OJPJQJ\_H 4@r4 !R0Header  H$FoF !R0 Header CharCJOJPJQJ_H aJ4 @4 !R0Footer  H$FoF !R0 Footer CharCJOJPJQJ_H aJPK![Content_Types].xmlN0EH-J@%ǎǢ|ș$زULTB l,3;rØJB+$G]7O٭V$ !)O^rC$y@/yH*񄴽)޵߻UDb`}"qۋJחX^)I`nEp)liV[]1M<OP6r=zgbIguSebORD۫qu gZo~ٺlAplxpT0+[}`jzAV2Fi@qv֬5\|ʜ̭NleXdsjcs7f W+Ն7`g ȘJj|h(KD- dXiJ؇(x$( :;˹! I_TS 1?E??ZBΪmU/?~xY'y5g&΋/ɋ>GMGeD3Vq%'#q$8K)fw9:ĵ x}rxwr:\TZaG*y8IjbRc|XŻǿI u3KGnD1NIBs RuK>V.EL+M2#'fi ~V vl{u8zH *:(W☕ ~JTe\O*tHGHY}KNP*ݾ˦TѼ9/#A7qZ$*c?qUnwN%Oi4 =3N)cbJ uV4(Tn 7_?m-ٛ{UBwznʜ"Z xJZp; {/<P;,)''KQk5qpN8KGbe Sd̛\17 pa>SR! 3K4'+rzQ TTIIvt]Kc⫲K#v5+|D~O@%\w_nN[L9KqgVhn R!y+Un;*&/HrT >>\ t=.Tġ S; Z~!P9giCڧ!# B,;X=ۻ,I2UWV9$lk=Aj;{AP79|s*Y;̠[MCۿhf]o{oY=1kyVV5E8Vk+֜\80X4D)!!?*|fv u"xA@T_q64)kڬuV7 t '%;i9s9x,ڎ-45xd8?ǘd/Y|t &LILJ`& -Gt/PK! ѐ'theme/theme/_rels/themeManager.xml.relsM 0wooӺ&݈Э5 6?$Q ,.aic21h:qm@RN;d`o7gK(M&$R(.1r'JЊT8V"AȻHu}|$b{P8g/]QAsم(#L[PK-![Content_Types].xmlPK-!֧6 0_rels/.relsPK-!kytheme/theme/themeManager.xmlPK-!0C)theme/theme/theme1.xmlPK-! ѐ' theme/theme/_rels/themeManager.xml.relsPK] A """""""""%T  3 @ @H 0(  0(  B S  ? Y  33'(LM/0YY4 4 B C X X Y  GsP2J 1ZS ^`OJQJo( 8^8`OJQJo(^`OJQJ^Jo(o  p^ `OJQJo(  @ ^ `OJQJo( x^x`OJQJo(H^H`OJQJ^Jo(o ^`OJQJo( ^`OJQJo( ^`OJQJo( ^`OJQJo(o p^p`OJQJo( @ ^@ `OJQJo( ^`OJQJo(o ^`OJQJo( ^`OJQJo( ^`OJQJo(o P^P`OJQJo(h^`OJQJo(hHh^`OJQJ^Jo(hHohp^p`OJQJo(hHh@ ^@ `OJQJo(hHh^`OJQJ^Jo(hHoh^`OJQJo(hHh^`OJQJo(hHh^`OJQJ^Jo(hHohP^P`OJQJo(hH ^`OJQJo( ^`OJQJo(o pp^p`OJQJo( @ @ ^@ `OJQJo( ^`OJQJo(o ^`OJQJo( ^`OJQJo( ^`OJQJo(o PP^P`OJQJo(1ZsP2                           ) +$&w11?9O= @ApGTAHLPf]DIufR0lI,<|Ki"ge#i~!!Rt_KI&^ @ @UnknownG*Ax Times New Roman5Symbol?. *Cx ArialArial7.@Calibri[Oh'Lucida GrandeCourier New?= *Cx Courier New;WingdingsA$BCambria Math hu(u(H*H*gڎ!24  3qHP ?R*!xx &Physician to Physician Letter Template Judi Croasmun Windows User    Oh+'0dx   , 8DLT\(Physician to Physician Letter TemplateJudi Croasmun Normal.dotmWindows User2Microsoft Office Word@@1@1H՜.+,0 hp  UPENN*  'Physician to Physician Letter Template Title  !"#$%&'(*+,-./0123456789:;<=>@ABCDEFHIJKLMNQRURoot Entry Fp2TData T01Table)*WordDocument SummaryInformation(?DocumentSummaryInformation8GMsoDataStore:2)2JOHMTREW43CNA==2:2)2Item  PropertiesUCompObj r   F Microsoft Word 97-2003 Document MSWordDocWord.Document.89q